Journals / Türkiye Aile Hekimliği Dergisi / 2006 / Cilt: 10 - Sayı: 2

Vaccination method against nicotine dependence: Is it a new hope?

Nikotin bağımlılığına karşı aşılama yöntemi: Yeni bir umut mu?

Pages
75–78
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this treatment, is to prevent nicotine from entering the brain, where it exerts its reinforcing effects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Drug addiction is a chronically relapsing brain disorder.
📊
Key Findings & Data:Smoking cigarette and related disorders are the most preventable cause of death.
💡
Conclusion & Impact:The aim of this treatment, is to prevent nicotine from entering the brain, where it exerts its reinforcing effects.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Drug addiction is a chronically relapsing brain disorder. Smoking cigarette and related disorders are the most preventable cause of death. Nicotine is the principal addictive component of tobac¬co. Nicotine produces a variety of effects in the brain to initiate and maintain tobacco dependence. Neural pathways involved in nicotine addiction, also serve to a variety of essential endoge¬nous functions. Altering functions of these pathways may cause side effect which limit the use of these drugs which also have a high relapse ratio. The limitation of previous nicotine dependence treatments, create a need for new treatment options. One of the newest approaches is immunization against nicotine. The aim of this treatment, is to prevent nicotine from entering the brain, where it exerts its reinforcing effects.

Özet

Madde bağımlılığı; kronik, tekrarlayan bir beyin hastalığıdır. Sigara içilmesi ile ilişkili hastalıklar, en fazla ölüme yol açan önlenebilir nedenlerden biridir. Tütünün içinde birinci derecede bağımlılık yapan etken madde nikotindir. Nikotin; beyinde, bağımlılığa yol açan birçok etkiye neden olur. Nikotin bağımlılığı ile ilişkili nöral yollar, birçok endojen fonksiyonda da görev alır. Tütün bağımlılığı, bu nöral yolları etkileyerek tedavi edilirken, birçok yanetkinin ortaya çıkması, bu tür ilaçların kullanımını kısıtlamaktadır. Üstelik bu ilaçlarla yüksek nüks oranları görülür. Nikotin bağımlılık tedavilerinin kısıtlılıkları ve yetersizlikleri yeni tedavi seçeneklerine ihtiyaç doğurmaktadır. Nikotine karşı bağışıklama, bu alandaki en yeni yaklaşımlardan biridir. Bu tedavinin amacı; nikotinin, pekiştirici et¬kisinin beyne ulaşmasını engellemektir.

🔖

Cite This Article

DOĞAN, Y. H., DEMİRGÖREN, S. (2022). Vaccination method against nicotine dependence: Is it a new hope?. Türkiye Aile Hekimliği Dergisi, Cilt: 10 - Sayı: 2, 75–78. https://ajindex.com/articles/626863

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Peto R. Smoking and death: the past 40 years and the next 40. BMJ 1994; 309(6959): 937-9
  2. Stolerman IP, Goldfarb T, Fink R, Jarvik ME. Influencing cigarette smoking with nicotine antagonists. Psychopharmacologia 1973; 28: 247-59
  3. Mansvelder HD, McGehee DS. Cellular and synaptic mechanisms of nicotine addiction. / Neurobiol 2002; 53: 606-17
  4. A US Public Health Service Report. A clinical practice guideline for treating tobacco use and dependence. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. Jama 2000; 283: 3244-54
  5. Jenner E. An inquiry into the causes and effects of the Variolae Vaccinae, a disease discovered in some of the western counties of England, particularly Gloucestershire, and known by the name of the cow-pox
  6. Baskı London: printed for the author by D.N.Shury, 1801. http://www.sc.edu/library/spcoll/nathist/jenner2.html adresinden 13/02/2006 tarihinde erişilmiştir
  7. Kösten T, Owens SM. Immunotherapy for the treatment of drug abuse. Pharmacol Ther 2005; 108: 76-85
  8. Lutwick LI. Unconventional vaccine targets. Immunization for pregnancy, peptic ulcer, gastric cancer, cocaine abuse, and atherosclerosis. Infect Dis Clin North Am 1999; 13:245-64
  9. Hieda Y, Keyler DE, Ennifar S, Fattom A, Pentel PR. Vaccination against nicotine during continued nicotine administration in rats: immunogenicity of the vaccine and effects on nicotine distribution to brain. Int J Immunopharmacol 2000; 22: 809-19
  10. Pentel PR, Malin DH, Ennifar S ve ark. A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats. Pharmacol Biochem Behav 2000; 65:191-8
  11. Owens SM, Mayersohn M. Phencyclidine-specific Fab fragments alter phencyclidine disposition in dogs. Drug Metab Dispos 1986; 14: 52-8
  12. Bonese KF, Wainer BH, Fitch FW, Rothberg RM, Schuster CR. Changes in heroin self-administration by a rhesus monkey after morphine immunisation. Nature 1974; 252(5485): 708-10
  13. Owens SM, Mayersohn M. Modulation of phencyclidine (PCP) pharmacokinetics with PCP-specific Fab fragments. NIDA Res Monogr 1986; 64: 112- 26
  14. Henningfield JE, Goldberg SR. Nicotine as a reinforcer in human subjects and laboratory animals. Pharmacol Biochem Behav 1983; 19: 989-92
  15. Henningfield JE, Keenan RM. Nicotine delivery kinetics and abuse liability. / Consult Clin Psychol 1993; 61: 743-50
  16. Palmer KJ, Buckley MM, Faulds D. Transdermal Nicotin